ResearcherFujian Medical UniversityNo recent work listed
Liang Wang
Matched on ORCID iD 0000-0002-5247-6727; OpenAlex author ID A5100456534. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 3 papers
Papers 6
- N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway. Co-author DOI 10.1186/s13062-022-00347-5↗
- N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer. Co-author DOI 10.1186/s13578-022-00844-0↗
- N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by competitively sponging miR-139-5p and activating the W… Co-author DOI 10.21203/rs.3.rs-1242747/v1↗
- MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition. First author DOI 10.1021/acsomega.1c02945↗
- microRNA-26a Inhibits the Malignant Tumor Behavior of Pancreatic Cancer Cells via Targeting E2F7 Co-author DOI 10.21203/rs.3.rs-37425/v1↗
- Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-… Co-author DOI 10.3389/fonc.2019.01464↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shangeng Weng · 3 shared papers, 2022 · strength 0.51
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the… DOI 10.1186/s13062-022-00347-5↗
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by competitively … DOI 10.21203/rs.3.rs-1242747/v1↗
- Paper N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancr… DOI 10.1186/s13578-022-00844-0↗
- Xiang Zhang · 3 shared papers, 2022 · strength 0.51
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the… DOI 10.1186/s13062-022-00347-5↗
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by competitively … DOI 10.21203/rs.3.rs-1242747/v1↗
- Paper N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancr… DOI 10.1186/s13578-022-00844-0↗
- Yan Wang · 3 shared papers, 2022 · strength 0.51
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the… DOI 10.1186/s13062-022-00347-5↗
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by competitively … DOI 10.21203/rs.3.rs-1242747/v1↗
- Paper N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancr… DOI 10.1186/s13578-022-00844-0↗
- Shihui Lai · 3 shared papers, 2022 · strength 0.51
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the… DOI 10.1186/s13062-022-00347-5↗
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by competitively … DOI 10.21203/rs.3.rs-1242747/v1↗
- Paper N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancr… DOI 10.1186/s13578-022-00844-0↗
- Chengjie Lin · 2 shared papers, 2022 · strength 0.33
- Paper N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the… DOI 10.1186/s13062-022-00347-5↗
- Paper N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancr… DOI 10.1186/s13578-022-00844-0↗
- Fei Chen · 1 shared paper, 2020 · strength 0.19
- Chengjie Lin · 1 shared paper, 2022 · strength 0.17
- Lisong Teng · 1 shared paper, 2021 · strength 0.17
- Jinxiao Liang · 1 shared paper, 2021 · strength 0.17
- Weitian Wei · 1 shared paper, 2021 · strength 0.17
- William Adrian Hall · 1 shared paper, 2019 · strength 0.11
- Haidy Gerges Nasief · 1 shared paper, 2019 · strength 0.11
- X. Allen Li · 1 shared paper, 2019 · strength 0.11
- Beth E. Erickson · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.